MedTrace Logo

Safety and Efficacy of the Bi-Aspheric Monofocal IOL

NCT06380478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-04-20

No results posted yet for this study

Summary

This is an observational, single-center, non-control, open-label post-marketing study. Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a follow-up visit at least 3 months after the surgery to undergo a routine basic ophthalmological examination.

Conditions

  • Cataract

Interventions

DEVICE

aspicio Monofocal IOL

A bi-aspheric monofocal IOL is implanted through preloaded IOL Delivery System in the capsular bag in the posterior chamber of the eye during cataract surgery

Sponsors & Collaborators

  • AST Products, Inc.

    collaborator INDUSTRY

  • ICARES Medicus, Inc.

    lead INDUSTRY

Principal Investigators

  • Yih-Shiou Hwang, MD · Chang Gung University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-05
Primary Completion
2025-08-12
Completion
2025-08-19

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06380478 on ClinicalTrials.gov